Key facts
- This page summarizes Eimear P. Bonner's Form 4 filing for CHEVRON CORP (CVX).
- 11 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2026, 18:25.
Eimear P. Bonner - 27 Feb 2026 Form 4 Insider Report for CHEVRON CORP (CVX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- CVX
- Reported as of
- 27 Feb 2026
- Net transaction value
- -$1,149,431
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 18:25:12 UTC
- Prior SEC filing
- 12 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rose Z. Pierson, Attorney-in-Fact for Eimear P. Bonner
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eimear P. Bonner filed Form 4 for CHEVRON CORP (CVX) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 12 Feb 2026.
- Current net transaction value: -$1,149,431.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001880440
Primary reporting owner
BONNER EIMEAR P
- Relationship
- Chief Financial Officer
- Address
- 1400 SMITH STREET, HOUSTON
- Signature
- /s/ Rose Z. Pierson, Attorney-in-Fact for Eimear P. Bonner
- Signature date
- 03 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVX
transaction
Common Stock
Options Exercise
- Transaction value
- $2,864,180
- Shares
- +18,800
- Change %
- +223%
- Price
- $152.35
- Shares after
- 27,228
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F2
CVX
transaction
Common Stock
Options Exercise
- Transaction value
- $1,470,912
- Shares
- +9,600
- Change %
- +35%
- Price
- $153.22
- Shares after
- 36,828
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
CVX
transaction
Common Stock
Sale
- Transaction value
- $1,013,527
- Shares
- -5,500
- Change %
- -15%
- Price
- $184.28
- Shares after
- 31,328
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F3
CVX
transaction
Common Stock
Sale
- Transaction value
- $463,334
- Shares
- -2,500
- Change %
- -8%
- Price
- $185.33
- Shares after
- 28,828
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F4
CVX
transaction
Common Stock
Sale
- Transaction value
- $3,376,745
- Shares
- -18,100
- Change %
- -63%
- Price
- $186.56
- Shares after
- 10,728
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F5
CVX
transaction
Common Stock
Sale
- Transaction value
- $430,469
- Shares
- -2,300
- Change %
- -21%
- Price
- $187.16
- Shares after
- 8,428
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F6
CVX
transaction
Common Stock
Options Exercise
- Transaction value
- $3,115,992
- Shares
- +17,400
- Change %
- +206%
- Price
- $179.08
- Shares after
- 25,828
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
CVX
transaction
Common Stock
Sale
- Transaction value
- $3,316,440
- Shares
- -17,400
- Change %
- -67%
- Price
- $190.60
- Shares after
- 8,427
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
CVX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 408
- Date
- 27 Feb 2026
- Ownership
- Share Incentive Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVX
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -18,800
- Change %
- -67%
- Price
- $0.000000
- Shares after
- 9,400
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,800
- Exercise price
- $152.35
- Footnotes
- F7
CVX
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -9,600
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 19,200
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,600
- Exercise price
- $153.22
- Footnotes
- F8
CVX
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -17,400
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 02 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,400
- Exercise price
- $179.08
- Footnotes
- F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 9 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2025.
Footnote F2
This number includes rounding of fractional shares.
Footnote F3
This transaction was executed in multiple trades at prices ranging from $183.85 to $184.82, inclusive. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form.
Footnote F4
These shares were sold in multiple transactions at prices ranging from $184.85 to $185.83, inclusive. The price reported in Column 4 reflects the weighted average sale price.
Footnote F5
These shares were sold in multiple transactions at prices ranging from $185.87 to $186.85, inclusive. The price reported in Column 4 reflects the weighted average sale price.
Footnote F6
These shares were sold in multiple transactions at prices ranging from $186.95 to $187.43, inclusive. The price reported in Column 4 reflects the weighted average sale price.
Footnote F7
Option granted 2/6/2024. One-third of the shares subject to the option vested on February 10, 2025 and February 10, 2026, respectively, and one-third of the shares will vest on February 10, 2027.
Footnote F8
Option granted 2/4/2025. One-third of the shares subject to the option vested on February 10, 2026 and one-third of the shares will vest on February 10, 2027 and February 10, 2028, respectively.
Footnote F9
Option granted 1/25/2023. One-third of the shares subject to the option vested on January 31, 2024, January 31, 2025 and January 31, 2026, respectively.